Cargando…
Girdin acts as an oncogene in gastric cancer by regulating AKT/GSK3β/β-catenin signaling
ThE present work focused on exploring Girdin expression within gastric cancer (GC), examining the effect of Girdin on the cell phenotype of GC, and clarifying the underlying mechanisms. Girdin expression in GC samples was identified by immunohistochemistry (IHC) and quantitative real-time PCR (qRT-P...
Autores principales: | Wang, Yun, Fu, Qiang, Tao, Yun-jian, Ying, Sheng-nan, Zhong, Heng-gao, Zhu, Yue, Qian, Xiao-han, Miao, Lin, Yang, Li-hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816263/ https://www.ncbi.nlm.nih.gov/pubmed/36604355 http://dx.doi.org/10.1007/s10142-022-00927-8 |
Ejemplares similares
-
Prognosis of gastric adenocarcinoma associated with girdin, Akt, and cortactin
por: Zhang, Yue, et al.
Publicado: (2022) -
Akt-Girdin as oncotarget
por: Takahashi, Masahide, et al.
Publicado: (2015) -
IGHG1 upregulation promoted gastric cancer malignancy via AKT/GSK-3β/β-Catenin pathway
por: Li, Xinyu, et al.
Publicado: (2021) -
MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma
por: Zhuang, Likun, et al.
Publicado: (2017) -
CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway
por: Wang, Chuanzheng, et al.
Publicado: (2023)